| 1 |
34907818 | Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials. | 2022 Apr |
1 |
| 2 |
35261444 | Prescribing patterns and outcomes among patients treated for gestational diabetes mellitus. | 2022 |
1 |
| 3 |
31733313 | Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease. | 2020 Feb 3 |
1 |
| 4 |
31989292 | Can glyburide be advocated over subcutaneous insulin for perinatal outcomes of women with gestational diabetes? A systematic review and meta-analysis. | 2020 Jan |
2 |
| 5 |
32274916 | Congenital diabetes mellitus. | 2020 Aug |
1 |
| 6 |
32442232 | Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis. | 2020 May |
2 |
| 7 |
30172767 | Analysis of the characteristics of patients with diabetes mellitus who attend a tertiary hospital emergency department for a hypoglycemic event. | 2019 Jan |
1 |
| 8 |
31292311 | The differential influence of glimepiride and glibenclamide on insulin resistance and adiponectin levels in patients with type 2 diabetes. | 2019 Oct 28 |
1 |
| 9 |
31479156 | Maternal and neonatal outcomes following a diabetic pregnancy within the context of HIV. | 2019 Dec |
1 |
| 10 |
31511772 | Glibenclamide-Induced Autophagy Inhibits Its Insulin Secretion-Improving Function in β Cells. | 2019 |
2 |
| 11 |
29305569 | Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation. | 2018 Mar 28 |
1 |
| 12 |
29679622 | Pharmacotherapy for hyperglycemia in pregnancy - Do oral agents have a place? | 2018 Nov |
1 |
| 13 |
30094785 | Successful Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Status in an Infant with KCNJ11-Related Neonatal Diabetes Mellitus via Continuous Renal Replacement Therapy. | 2018 Oct |
1 |
| 14 |
27316908 | Mechanism of Action of Novel Glibenclamide Derivatives on Potassium and Calcium Channels for Insulin Secretion. | 2017 |
1 |
| 15 |
28077460 | Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. | 2017 Mar |
1 |
| 16 |
28556992 | Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer. | 2017 Oct |
1 |
| 17 |
28930827 | Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis. | 2017 Sep |
1 |
| 18 |
28938877 | Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial. | 2017 Sep 22 |
1 |
| 19 |
26609764 | Effects of antidiabetic agents on pancreatic beta-cell function in gestational diabetes: is there enough evidence? | 2016 |
1 |
| 20 |
26796130 | Predicting failure of glyburide therapy in gestational diabetes. | 2016 May |
2 |
| 21 |
26831749 | Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis. | 2016 Aug |
1 |
| 22 |
27163280 | Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. | 2016 Jun |
1 |
| 23 |
25297572 | The effect of glibenclamide on insulin secretion at normal glucose concentrations. | 2015 Jan |
2 |
| 24 |
25665835 | Lack of glibenclamide response in a case of permanent neonatal diabetes caused by incomplete inactivation of glucokinase. | 2015 |
1 |
| 25 |
25765720 | Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals. | 2015 Jun |
1 |
| 26 |
26132275 | Potentiation of Glibenclamide Hypoglycaemia in Mice by MK-467, a Peripherally Acting Alpha2-Adrenoceptor Antagonist. | 2015 Dec |
1 |
| 27 |
26331221 | Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea. | 2015 Dec |
1 |
| 28 |
26438710 | Case Report: When an Induced Illness Looks Like a Rare Disease. | 2015 Nov |
2 |
| 29 |
26548081 | Interaction of mouse intestinal P-glycoprotein with oral antidiabetic drugs and its inhibitors. | 2015 Sep |
1 |
| 30 |
24150606 | OATP1B3 is expressed in pancreatic β-islet cells and enhances the insulinotropic effect of the sulfonylurea derivative glibenclamide. | 2014 Feb |
2 |
| 31 |
24741335 | Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study. | 2014 |
1 |
| 32 |
24767162 | [An analysis of hypoglycemic agents used among patients with type 2 diabetes in Beijing communities]. | 2014 Feb |
2 |
| 33 |
25315294 | Gestational diabetes mellitus management with oral hypoglycemic agents. | 2014 Dec |
1 |
| 34 |
25580176 | Review of metformin and glyburide in the management of gestational diabetes. | 2014 Oct |
1 |
| 35 |
22982177 | Evaluating insulin secretagogues in a humanized mouse model with functional human islets. | 2013 Jan |
1 |
| 36 |
23179858 | Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin model. | 2013 Feb |
2 |
| 37 |
23413771 | A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy. | 2013 Jul |
2 |
| 38 |
23427864 | A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study. | 2013 Mar |
2 |
| 39 |
23921548 | The TRPA1 channel and oral hypoglycemic agents: is there complicity in β-cell exhaustion? | 2013 Nov-Dec |
2 |
| 40 |
24275850 | Glibenclamide for the treatment of acute CNS injury. | 2013 Oct 11 |
2 |
| 41 |
22768668 | Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy. | 2012 |
1 |
| 42 |
21175273 | Effect of repaglinide versus glyburide on postprandial glucose and insulin values in elderly patients with type 2 diabetes. | 2011 Jan |
2 |
| 43 |
21792527 | Comparison of antihyperglycemic effects of creatine and glibenclamide in type II diabetic patients. | 2011 Nov |
2 |
| 44 |
19656320 | Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation. | 2010 Jun |
1 |
| 45 |
20540435 | [Low doses of sulphonyluria as a successful replacement for insulin therapy in a patient with neonatal diabetes due to a mutation of KCNJ11 gene encoding Kir6.2]. | 2010 Mar-Apr |
1 |
| 46 |
20804735 | Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. | 2010 Sep 24 |
1 |
| 47 |
20814548 | Insulin-induced electrophysiology changes in human pleura are mediated via its receptor. | 2010 |
1 |
| 48 |
21426008 | Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription. | 2010 Apr |
1 |
| 49 |
19295505 | Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. | 2009 Jun |
1 |
| 50 |
19502091 | Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide. | 2009 Sep |
2 |